Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul;62(Suppl2):143-147.
doi: 10.20471/acc.2023.62.s2.21.

SACRAL NEUROMODULATION IN TREATING OVERACTIVE BLADDER PATIENTS - FIRST-TIME APPLICATION IN CROATIA

Mirko Bakula  1 , Dinko Hauptman  1 , Tvrtko Hudolin  1 , Sandra Nađ Škegro  1 , Katarina Ivana Tudor  2 , Branko Bakula  3 , Željko Kaštelan  1
Affiliations
Review

SACRAL NEUROMODULATION IN TREATING OVERACTIVE BLADDER PATIENTS - FIRST-TIME APPLICATION IN CROATIA

Mirko Bakula et al. Acta Clin Croat. 2023 Jul.

Abstract

Sacral neuromodulation (SNM) is a safe, efficacious, and minimally invasive advanced therapy that involves electrical stimulation to sacral nerve root to modulate neural pathway. Indications for SNM include symptoms of overactive bladder (OAB), urinary incontinence, urinary retention, urgency and frequency and, regarding bowel dysfunction, fecal incontinence . In Europe and Canada, indication is also established for chronic constipation. The mechanism of action is still not fully elucidated and complete understanding is yet to be determined. It is proposed that SNM modulates neural circuits in both central and peripheral pathways, thus having an impact on the brain, as well as on the bladder-targeting neuronal activity. Another possible significant effect on irregular bladder activity is through inhibition of the bladder afferent pathways by stimulation of the pudendal nerve. Over the past two decades, with more than 300 000 treated patients, SNM has confirmed its efficacy to relieve refractory OAB symptoms, as well as urinary retention or fecal incontinence. First SNM applications in Croatia were uneventful and we are glad to offer our patients this novel therapy in the future.

Keywords: Croatia; Overactive bladder; Sacral neuromodulation.

PubMed Disclaimer

References

    1. Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015. March;34(3):224–30. 10.1002/nau.22544 - DOI - PubMed
    1. Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, et al. Three-year follow-up results of a prospective, multicenter study in overactive bladder subjects treated with sacral neuromodulation. Urology. 2016. August;94:57–63. 10.1016/j.urology.2016.04.024 - DOI - PubMed
    1. Tanagho EA, Schmidt RA. Bladder pacemaker: scientific basis and clinical future. Urology. 1982. December;20(6):614–9. 10.1016/0090-4295(82)90312-0 - DOI - PubMed
    1. Goldman HB, Lloyd JC, Noblett KL, Carey MP, Casta Ño-Botero JC, Gajewski JB, et al. International Continence Society best practice statement for use of sacral neuromodulation. Neurourol Urodyn. 2018. June;37(5):1821–2. 10.1002/nau.23596 - DOI - PubMed
    1. Maeda Y, O’Connell PR, Lehur PA, Matzel KE, Laurberg S, European SNS Bowel Study Group . Sacral nerve stimulation for faecal incontinence and constipation: a European consensus statement. Colorectal Dis. 2015. April;17(4):O74–87. 10.1111/codi.12905 - DOI - PubMed

LinkOut - more resources